skip to Main Content


Latest News, Announcements, and Press Releases

06May 19

Codexis Reports First Quarter 2019 Financial Results

Total revenues increase 11% to $15.6 million , product revenue up 30% Recent highlights include Third CodeEvolver ® Platform Technology Agreement and Multi-Year Enzyme Supply and Licensing Agreement with Tate & Lyle for TASTEVA ® M Stevia Sweetener Conference call…
read more
05Mar 19

Codexis to Participate in Two Investment Conferences in March

REDWOOD CITY, Calif. , March 05, 2019 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that management will participate in two upcoming investment conferences: Cowen and Company 39 th Annual Health Care Conference on Tuesday,…
read more

Since 2002, Codexis has created new technologies to unlock the power of proteins®. Put our unmatched protein engineering expertise to work for you.

Unlock the power of proteins® with Codexis

Back To Top
Close search